LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.50 | 21.74 | 1064 | 5425 | 0.1961 | 0.6300 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.50 | 21.74 | 30 | 5425 | 0.0055 | 0.0413 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.50 | 21.74 | 1252 | 5425 | 0.2308 | 0.6636 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 21.74 | 1053 | 5768 | 0.1825 | 0.6192 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 21.74 | 1067 | 5768 | 0.1850 | 0.6218 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 21.74 | 47 | 5768 | 0.0081 | 0.1005 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 55.48 | 21.74 | 1261 | 5768 | 0.2186 | 0.6558 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.45 | 21.74 | 1060 | 6023 | 0.1760 | 0.6145 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.45 | 21.74 | 1074 | 6023 | 0.1783 | 0.6171 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.45 | 21.74 | 48 | 6023 | 0.0080 | 0.1025 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 57.45 | 21.74 | 1283 | 6023 | 0.2130 | 0.6529 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 59.42 | 21.74 | 1071 | 6125 | 0.1749 | 0.6143 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 59.42 | 21.74 | 1087 | 6125 | 0.1775 | 0.6172 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 59.42 | 21.74 | 44 | 6125 | 0.0072 | 0.0905 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 59.42 | 21.74 | 1301 | 6125 | 0.2124 | 0.6533 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.39 | 21.74 | 1104 | 6112 | 0.1806 | 0.6206 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.39 | 21.74 | 1118 | 6112 | 0.1829 | 0.6231 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.39 | 21.74 | 55 | 6112 | 0.0090 | 0.1209 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 62.39 | 21.74 | 1317 | 6112 | 0.2155 | 0.6561 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.36 | 21.74 | 1101 | 6191 | 0.1778 | 0.6183 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.36 | 21.74 | 1112 | 6191 | 0.1796 | 0.6202 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.36 | 21.74 | 60 | 6191 | 0.0097 | 0.1326 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.36 | 21.74 | 1326 | 6191 | 0.2142 | 0.6556 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 66.33 | 21.74 | 1114 | 6235 | 0.1787 | 0.6196 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 66.33 | 21.74 | 1124 | 6235 | 0.1803 | 0.6214 | MN20160310_N01 | D07 |